In the early online edition of PNAS, scientists from Imperial College London and Pfizer report a successful application of metabolic profiling. Using NMR to profile the urine of 99 men who were given acetaminophen, they found that those with higher initial levels of p-cresol sulfate metabolized the drug less effectively than those with lower levels.